Expression ofPlasmodium falciparum3D7 STEVOR proteins for evaluation of antibody responses following malaria infections in naïve infants

Authors:

Abstract
SUMMARY: Clinical immunity toPlasmodium falciparummalaria develops after repeated exposure to the parasite. At least 2P. falciparumvariant antigens encoded by multicopy gene families (varandrif) are targets of this adaptive antibody-mediated immunity. A third multigene family of variant antigens comprises thestevorgenes. Here, 4 differentstevorsequences were selected for cloning and expression inEscherichia coliand His6–tagged fusion proteins were used for assessing the development of immunity. In a cross-sectional analysis of clinically immune adults living in a malaria endemic area in Ghana, high levels of anti-STEVOR IgG antibody titres were determined in ELISA. A cross-sectional study of 90 nine-month-old Ghanaian infants using 1 recombinant STEVOR showed that the antibody responses correlated positively with the number of parasitaemia episodes. In a longitudinal investigation of 17 immunologically naïve 9-month-old infants, 3 different patterns of anti-STEVOR antibody responses could be distinguished (high, transient and low). Children with high anti-STEVOR-antibody levels exhibited an elevated risk for developing parasitaemia episodes. Overall, a protective effect could not be attributed to antibodies against the STEVOR proteins chosen for the study presented here.

This publication has 35 references indexed in Scilit: